Jump to content

Recommended Posts

Posted
1 hour ago, Spekulatius said:

A starter in FISV and a small add to VNT.

 

Consider a look at Israeli based payment co, Shva.

Posted
8 hours ago, n.r98 said:

 

Consider a look at Israeli based payment co, Shva.

re SHVA - I have it on my watch list. I think it has been a Kuppy pick, or someone else from FinTwit. it seems to trade at roughly similar metrics than FISV, but with better growth.

I did not feel that the risk from the “antitrust” like lawsuit from the regulator and the fact that it operates in a not so geopolitical stable area (Israel) makes it that great of a bargain.

Posted
On 4/22/2021 at 1:19 PM, LC said:

I did the same. Prefer puts but the premium is a bit high.

NFLX has quite a bit of headwinds ahead of it. Competition is not going anywhere and will just intensify, I am not sure where they can squeeze additional growth, and with COVID winding down, my guess is more people would prefer to be outside vs. their living room.

I also rarely short so this is a smaller % of the portfolio compared to Greg's above.

Horrible numbers. Can't believe people are actually buying this here. 

Posted

Got loose confirmation that there is indeed some retard with a semi sized fund liquidating MSGE, so Im buying more. Added little bit more ALCO as well. Shorted more CLF puts.

Posted
17 hours ago, Gregmal said:

Got loose confirmation that there is indeed some retard with a semi sized fund liquidating MSGE, so Im buying more. Added little bit more ALCO as well. Shorted more CLF puts.

MSGE Wasn't on my radar. After having a good look, that can be added to my buy list! Thanks!

Posted

Wrote some GOTU Aug 2.50 puts. Very speculative, but it's a 15% return in just four weeks, and I have to think they'll still be at least some hope by then that shareholders won't be wiped out by the CCP. I've had good luck in the past writing OTM puts on absolute trash stocks like Luckin Coffee, or massively overvalued ones like GME and AMC, and hoping that streak continues.

Posted

Bought some food for the kids on the way to the shore this morning. When the heck did McDonalds become so expensive? Ordered 2 hash browns(used to be .99 each) and a sausage egg and cheese(IIRC always like $3...was featured in the Buffett HBO doc!) and it was $8.30! Then went across to Burger King and got a jr cheeseburger, 10 piece chicken nuggets(same 10 piece nugget at MCD are like $5), a rodeo burger, small fries, mozzarella sticks, and a chocolate milk...for $8.74. 

 

I dont know why anyone would ever eat at MCD...only attraction used to be how cheap the food is. Now the same dogshit, plastic play food is more expensive than Burger King or Wendys and both of the later choices are significantly better quality. 

 

Posted

Bought some MEGACPO again (Mexican cable co). The first time didn’t work out as I sold when Mexico went into a COVID-19 tailspin. Perhaps now the second time does the trick.

 

Seems eternally cheap though.

Posted
4 hours ago, bathtime said:


What’s your thesis on CRBU in relation to other CRISPR companies? Thanks!

 

Caribou has long been a private market white whale of mine. I generally have pretty good luck snagging private shares in companies I like but this one always evaded me, including a few ROFRs. I wrote up the entire CRISPR theme here some years ago, and like most wildly successful investments here, it was largely an unpopular thread and IIRC met with a lot of skepticism or critique. At the time, you could buy every real public market CRISPR play for a valuation of less than $5B. Today that number is north of $40B or so. Theres been some major developments, but in terms of the players, the main thing is that EDIT is an established turd and NTLA has made some serious progress. 

 

The only two major players that Im aware of that remained non public were Caribou and Synthego. So now that CRBU is public I just bit the bullet and bought a position. I dont even think the valuation, net cash, is that egregious. Caribou has always kind of been more secretive and stands out IMO as having the greatest IP protections and pipeline to new CRISPR uses through the platform along with maybe BEAM.

Posted
5 hours ago, Gregmal said:

 

Caribou has long been a private market white whale of mine. I generally have pretty good luck snagging private shares in companies I like but this one always evaded me, including a few ROFRs. I wrote up the entire CRISPR theme here some years ago, and like most wildly successful investments here, it was largely an unpopular thread and IIRC met with a lot of skepticism or critique. At the time, you could buy every real public market CRISPR play for a valuation of less than $5B. Today that number is north of $40B or so. Theres been some major developments, but in terms of the players, the main thing is that EDIT is an established turd and NTLA has made some serious progress. 

 

The only two major players that Im aware of that remained non public were Caribou and Synthego. So now that CRBU is public I just bit the bullet and bought a position. I dont even think the valuation, net cash, is that egregious. Caribou has always kind of been more secretive and stands out IMO as having the greatest IP protections and pipeline to new CRISPR uses through the platform along with maybe BEAM.

 

Thanks, that's great color on both Caribou and other CRISPR names! Appreciate it. And really interesting to hear that you've been tracking it for so long — and rate the IP as quality. 

Posted

Since my last post on Thursday:

 

Bought: FRFHF (fist time I've owned it in quite a few years) & CRBU

Added to: ALCO, ATCO, APTS,  & NVDA


Sold all: FB & GOOGL.

Sold some: AXON, NTAP, PSTH, MSTR, & TRUP
 

Posted
15 hours ago, bathtime said:

 

Thanks, that's great color on both Caribou and other CRISPR names! Appreciate it. And really interesting to hear that you've been tracking it for so long — and rate the IP as quality. 

 

At $16/share, if underwriters exercise their option for additional shares, CRBU has market cap of approx. $916m with cash of approx. $398m. Seems like a relative value compared to other CRISPR companies.

Posted
1 hour ago, bathtime said:

 

At $16/share, if underwriters exercise their option for additional shares, CRBU has market cap of approx. $916m with cash of approx. $398m. Seems like a relative value compared to other CRISPR companies.

Yea the bankers quite regularly seem to fall back on internal models which price these based on what phase a biotech company is in or how far away they are from generating revenue. Same thing happened with BEAM and not much later it was a 5 bagger. Not saying the same occurs with CRBU, but what I will say is that I would have paid more than the current market cap to own shares pre IPO. So I like it here. Doesnt take much to start moving the needle, as we just saw with NTLA the past year. 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...